全文获取类型
收费全文 | 211978篇 |
免费 | 3028篇 |
国内免费 | 230篇 |
专业分类
耳鼻咽喉 | 1557篇 |
儿科学 | 7339篇 |
妇产科学 | 3342篇 |
基础医学 | 21147篇 |
口腔科学 | 2559篇 |
临床医学 | 14947篇 |
内科学 | 40146篇 |
皮肤病学 | 1499篇 |
神经病学 | 19160篇 |
特种医学 | 10332篇 |
外科学 | 34662篇 |
综合类 | 2534篇 |
一般理论 | 1篇 |
预防医学 | 19327篇 |
眼科学 | 3241篇 |
药学 | 12447篇 |
中国医学 | 697篇 |
肿瘤学 | 20299篇 |
出版年
2023年 | 282篇 |
2022年 | 570篇 |
2021年 | 957篇 |
2020年 | 460篇 |
2019年 | 666篇 |
2018年 | 22594篇 |
2017年 | 17931篇 |
2016年 | 20137篇 |
2015年 | 1701篇 |
2014年 | 1842篇 |
2013年 | 1990篇 |
2012年 | 8790篇 |
2011年 | 22815篇 |
2010年 | 19822篇 |
2009年 | 12355篇 |
2008年 | 20980篇 |
2007年 | 23234篇 |
2006年 | 2189篇 |
2005年 | 3879篇 |
2004年 | 4902篇 |
2003年 | 5768篇 |
2002年 | 3940篇 |
2001年 | 1496篇 |
2000年 | 1764篇 |
1999年 | 1359篇 |
1998年 | 622篇 |
1997年 | 518篇 |
1996年 | 406篇 |
1995年 | 370篇 |
1994年 | 355篇 |
1993年 | 312篇 |
1992年 | 845篇 |
1991年 | 809篇 |
1990年 | 855篇 |
1989年 | 855篇 |
1988年 | 762篇 |
1987年 | 677篇 |
1986年 | 631篇 |
1985年 | 601篇 |
1984年 | 463篇 |
1983年 | 353篇 |
1982年 | 212篇 |
1980年 | 199篇 |
1979年 | 287篇 |
1978年 | 231篇 |
1977年 | 177篇 |
1974年 | 184篇 |
1970年 | 164篇 |
1969年 | 191篇 |
1968年 | 165篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Kazunori Aizawa Takeshi Hanaoka Hiroki Kasai Kaoru Kogashi Setsuo Kumazaki Jun Koyama Hiroshi Tsutsui Yoshikazu Yazaki Noboru Watanabe Osamu Kinoshita Uichi Ikeda 《Hypertension research》2006,29(2):123-128
The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more potent and selective PDE-5 inhibitor than sildenafil, has been approved for the treatment of erectile dysfunction. However, the long-term effects of oral vardenafil in patients with PH are unknown. We studied five consecutive patients with PH; one with primary pulmonary hypertension, two with chronic pulmonary thromboembolism, one with Eisenmenger syndrome (ventricular septal defect) and one with secondary pulmonary hypertension after a ventricular septal defect closure operation. In an acute hemodynamic trial, vardenafil (5 mg) significantly decreased both the pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) with an increase in cardiac output. In a chronic hemodynamic trial, the maintenance dose of vardenafil (10 to 15 mg) for 3 months significantly decreased the PVR, but not the SVR, with a 20.7% reduction of the PVR/ SVR ratio. Plasma brain natriuretic peptide (BNP) levels were also significantly decreased after 3 months. This pilot study demonstrates that long-term oral vardenafil therapy may be a safe and effective treatment for patients with PH. 相似文献
22.
Daisuke Kubota Chizuru Takishima Ken-ichi Ishii Takahiro Kawamura Tomoko Matsumoto Yasuhiro Itsui Eriko Okada Seishin Chin Shinya Oooka Kiichiro Tsuchiya Akihiro Araki Naoya Sakamoto Tatsuya Miyata Takanori Kanai Mamoru Watanabe 《Nihon Shokakibyo Gakkai zasshi》2006,103(9):1044-1049
A 23-year-old man was admitted for treatment of acute exacerbation of ileitis and perianal abscess caused by Crohn's disease. After incision and drainage of the abscess, coupled with antibiotic therapy, 6-mercaptopurine (6-MP) was commenced. His white blood cell (WBC) count on day 12 after initiation of 6-MP was not decreased. However, on day 24 he was re-admitted because of severe myelosuppression (WBC: 300/microl), which was complicated by the recurrence of the perianal abscess. Myelosuppression was prolonged and required the administration of granulocyte colony stimulating factor (G-CSF). G-CSF was continued for 17 days to achieve recovery of his WBC count to a normal level. 相似文献
23.
24.
25.
26.
27.
28.
29.
30.